Funding Clinical Trials

Our Agency funds clinical trials testing promising stem cell or gene therapies for currently incurable diseases or disorders to help patients with unmet medical needs. For basic information about stem cell trials, visit our Clinical Trials 101 page. For a list of clinical trials that are a result of early-stage CIRM grants click here.

106

CIRM-FUNDED CLINICAL TRIALS

Disease Areas	Investigator	Organization	Phase	Trial Status	Target Enrollment
Brain Cancer	Dr. Christine E. Brown	City of Hope, Beckman Research Institute	Phase 1	Active, not recruiting	82
Lung Cancer	Steven M. Dubinett	University of California, Los Angeles	Phase 1	Active, not recruiting	24
Melanoma	Robert Dillman	Caladrius Biosciences	Phase 3	Closed	4
Melanoma Skin cancer	Dr. Antoni Ribas MD/PhD	University of California, Los Angeles	Phase 1	Closed	5
Sarcoma	Theodore Scott Nowicki	University of California, Los Angeles	Phase 1	Closed	5
Blood Cancer Solid Tumors	Dr. Irving L Weissman MD	Stanford University	Phase 1	Completed	88
Solid Tumors	Dr. Dennis J Slamon	University of California, Los Angeles	Phase 1	Completed	46
Colon Cancer	Mark Chao	Forty Seven Inc.	Phase 1/2	Completed	78
Brain Cancer	Dr Jana Portnow	City of Hope, Beckman Research Institute	Phase 1	Launching	N/A
Colon Cancer	Ivan King	Tachyon Therapeutics, Inc	Phase 1	Launching	N/A
Solid Tumors	Pei Wang	Eureka Therapeutics, Inc.	Phase 1/2	Launching	N/A
Brain Cancer	Dr. Reena Parada Thomas	Stanford University	Phase 1	Launching	N/A
Melanoma	Anusha Kalbasi	Stanford University	Phase 1	Launching	N/A
Brain Cancer	Dr. Hideho Okada	University of California, San Francisco	Phase 1	Launching	N/A
Solid Tumors	Dr. John Le Gall	Allogene Therapeutics	Phase 1	Launching	N/A
Brain Cancer Breast Cancer	Dr Saul J Priceman	City of Hope, Beckman Research Institute	Phase 1	Recruiting	39
Brain Cancer	Dr. Leo D Wang	City of Hope, Beckman Research Institute	Phase 1	Recruiting	18
Brain Cancer	Crystal Mackall	Stanford University	Phase 1	Recruiting	54
Solid Tumors	Dr. Pamela Reilly Contag	BioEclipse Therapeutics INC.	Phase 1	Recruiting	60
Brain Cancer	Anthony J. Gringeri	ImmunoCellular Therapeutics	Phase 3	Suspended	234